Correlation Between Cytek Biosciences and Health Catalyst

Can any of the company-specific risk be diversified away by investing in both Cytek Biosciences and Health Catalyst at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytek Biosciences and Health Catalyst into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cytek Biosciences and Health Catalyst, you can compare the effects of market volatilities on Cytek Biosciences and Health Catalyst and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytek Biosciences with a short position of Health Catalyst. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytek Biosciences and Health Catalyst.

Diversification Opportunities for Cytek Biosciences and Health Catalyst

0.19

Correlation Coefficient

Cytek Biosciences  Health Catalyst

Average diversification

The 3 months correlation between Cytek and Health is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Cytek Biosciences and Health Catalyst in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Health Catalyst and Cytek Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytek Biosciences are associated (or correlated) with Health Catalyst. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Health Catalyst has no effect on the direction of Cytek Biosciences i.e., Cytek Biosciences and Health Catalyst go up and down completely randomly.

Pair Corralation between Cytek Biosciences and Health Catalyst

Given the investment horizon of 90 days Cytek Biosciences is expected to generate 1.6 times more return on investment than Health Catalyst. However, Cytek Biosciences is 1.6 times more volatile than Health Catalyst. It trades about 0.03 of its potential returns per unit of risk. Health Catalyst is currently generating about -0.03 per unit of risk. If you would invest  379.00  in Cytek Biosciences on May 8, 2025 and sell it today you would earn a total of  9.00  from holding Cytek Biosciences or generate 2.37% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cytek Biosciences  vs.  Health Catalyst

Cytek Biosciences

Risk-Adjusted Performance

Soft

Compared to the overall equity markets, risk-adjusted returns on investments in Cytek Biosciences are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain forward-looking signals, Cytek Biosciences may actually be approaching a critical reversion point that can send shares even higher in September 2025.

Health Catalyst

Risk-Adjusted Performance

Weakest

Over the last 90 days Health Catalyst has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Health Catalyst is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Cytek Biosciences and Health Catalyst

The main advantage of trading using opposite Cytek Biosciences and Health Catalyst positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytek Biosciences position performs unexpectedly, Health Catalyst can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Health Catalyst will offset losses from the drop in Health Catalyst's long position.

The idea behind Cytek Biosciences and Health Catalyst pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.